Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Operating Grant - Priority Announcement: Breast Cancer

University of Toronto

$100,000.00

Engineering DNA-nanosystems for tumor targeting

EF 2012-13

Résumé
The survival of patients with breast cancer improves dramatically when they are diagnosed early. One of the biggest challenges in diagnosing or treating cancer is to be able to deliver enough of a small molecule diagnostic or therapeutic agent to the tumor. Recently, it has been demonstrated that the size, shape, and surface chemistry of a delivery system can influence how much of the agent is delivered into a tumor. In my previous CIHR funded grant, we identified specific design parameters for building the optimal delivery vehicle to target tumors. In this renewal application, we propose to use DNA to build these optimal nanoparticle-delivery systems. We will use a combination of DNA, synthetic polymer polyethylene glycol, and gold nanoparticles, to construct a library of nanosystems. We will then test the targeting or delivery efficiency in cells, tissues, and in whole animals. Using these biological models, we will be identify the optimal design and test how much of an improvement in diagnostic sensitivity. The outcome of this important study is the development of new nanotechnology-based delivery vehicles for diagnosing and treating cancer.
Programme
Operating Grant - Priority Announcement: Breast Cancer
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
273824
Name
Chan Warren C
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Biomedical Engineering
Projecttitle
Engineering DNA-nanosystems for tumor targeting
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant - Priority Announcement: Breast Cancer
Keyworddelim
Biomedical Enginering; Breast Cancer; Dna Assembly; Nanotechnology; Targeting
Abstract
The survival of patients with breast cancer improves dramatically when they are diagnosed early. One of the biggest challenges in diagnosing or treating cancer is to be able to deliver enough of a small molecule diagnostic or therapeutic agent to the tumor. Recently, it has been demonstrated that the size, shape, and surface chemistry of a delivery system can influence how much of the agent is delivered into a tumor. In my previous CIHR funded grant, we identified specific design parameters for building the optimal delivery vehicle to target tumors. In this renewal application, we propose to use DNA to build these optimal nanoparticle-delivery systems. We will use a combination of DNA, synthetic polymer polyethylene glycol, and gold nanoparticles, to construct a library of nanosystems. We will then test the targeting or delivery efficiency in cells, tissues, and in whole animals. Using these biological models, we will be identify the optimal design and test how much of an improvement in diagnostic sensitivity. The outcome of this important study is the development of new nanotechnology-based delivery vehicles for diagnosing and treating cancer.
Competitiondate
201209
Approvedterm2
1 yr 0 mth
Pinamesdelim
Chan, Warren C
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~